Xinlin Yu

No. 25 Taiping Street, Jiangyang District
Luzhou, 646000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Conversion hepatectomy and survival in initially unresectable hepatocellular carcinoma: a systematic review and meta-analysis with quantitative bias analysis.

Conversion hepatectomy and survival in initially unresectable hepatocellular carcinoma: a systematic review and meta-analysis with quantitative bias analysis.

Journal: World journal of surgical oncology

Published: May 12, 2026

Efficacy and Safety of Regorafenib with or without Immune Checkpoint Inhibitors as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Systematic Review and Arm-Level Synthesis of Real-World Comparative Cohorts.

Efficacy and Safety of Regorafenib with or without Immune Checkpoint Inhibitors as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Systematic Review and Arm-Level Synthesis of Real-World Comparative Cohorts.

Journal: OncoTargets and therapy

Published: March 02, 2026

Efficacy and safety of blinatumomab combination therapy in high-risk B-cell acute lymphoblastic leukemia: A systematic review and meta-analysis.

Efficacy and safety of blinatumomab combination therapy in high-risk B-cell acute lymphoblastic leukemia: A systematic review and meta-analysis.

Journal: Oncology letters

Published: November 08, 2025

Global comorbidity of ischemic heart disease and liver cancer: an ecological analysis of shared risk factors.

Global comorbidity of ischemic heart disease and liver cancer: an ecological analysis of shared risk factors.

Journal: Annals of medicine and surgery (2012)

Published: October 16, 2025

Lipid-Lowering Efficacy and Adverse Events of CETP Inhibitor Combination Therapy: A Systematic Review and Network Meta-Analysis.

Lipid-Lowering Efficacy and Adverse Events of CETP Inhibitor Combination Therapy: A Systematic Review and Network Meta-Analysis.

Journal: Journal of cardiovascular pharmacology

Published: October 16, 2025

The Efficacy and Safety of Anlotinib Combination Therapy for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

The Efficacy and Safety of Anlotinib Combination Therapy for Advanced Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.

Journal: Cancer control : journal of the Moffitt Cancer Center

Published: October 15, 2025

Epigenetic and metabolic reprogramming via nanotechnology: a synergistic approach to cancer vaccination in lung tumors.

Epigenetic and metabolic reprogramming via nanotechnology: a synergistic approach to cancer vaccination in lung tumors.

Journal: Frontiers in genetics

Published: August 21, 2025

Safety and efficacy of radiotherapy combined with immunotherapy in limited-stage small cell lung cancer a single-arm meta-analysis and systematic review.

Safety and efficacy of radiotherapy combined with immunotherapy in limited-stage small cell lung cancer a single-arm meta-analysis and systematic review.

Journal: PloS one

Published: July 21, 2025

Disrupting PDGFRA-driven immune evasion in glioma: vaccine-based strategies on the horizon.

Disrupting PDGFRA-driven immune evasion in glioma: vaccine-based strategies on the horizon.

Journal: Frontiers in oncology

Published: July 15, 2025

Comparative efficacy and safety of immune checkpoint inhibitors-based strategies in advanced hepatocellular carcinoma: a systematic review and network meta-analysis.

Comparative efficacy and safety of immune checkpoint inhibitors-based strategies in advanced hepatocellular carcinoma: a systematic review and network meta-analysis.

Journal: International journal of surgery (London, England)

Published: July 04, 2025

Efficacy and safety of EGFR-TKI for EGFR-mutated NSCLC: systematic review and network meta-analysis.

Efficacy and safety of EGFR-TKI for EGFR-mutated NSCLC: systematic review and network meta-analysis.

Journal: International journal of clinical and experimental pathology

Published: April 27, 2025

Evaluation of the efficacy and safety of durvalumab combined with chemotherapy, radiotherapy, or other agents in advanced non-small cell lung cancer: a meta-analysis.

Evaluation of the efficacy and safety of durvalumab combined with chemotherapy, radiotherapy, or other agents in advanced non-small cell lung cancer: a meta-analysis.

Journal: International journal of clinical and experimental pathology

Published: February 21, 2025

Showing 1-12 of 20

Last Updated: 09/26/2026